These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 14731700)

  • 1. Quality assurance in breast screening in Europe.
    Perry N
    Breast; 2000 Apr; 9(2):61-5. PubMed ID: 14731700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
    Arbyn M; Dillner J
    J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance and benchmarking: an approach for European dental schools.
    Jones ML; Hobson RS; Plasschaert AJ; Gundersen S; Dummer P; Roger-Leroi V; Sidlauskas A; Hamlin J
    Eur J Dent Educ; 2007 Aug; 11(3):137-43. PubMed ID: 17640256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The EQUAL-ESTRO external quality control laboratory in France].
    Roué A; Van Dam J; Dutreix A; Svensson H
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S44-9. PubMed ID: 15679246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer screening--the European experience.
    Perry NM
    Int J Fertil Womens Med; 2004; 49(5):228-30. PubMed ID: 15633481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of primary care in colorectal cancer screening: experience from Czech Republic.
    Seifert B; Zavoral M; Fric P; Bencko V
    Neoplasma; 2008; 55(1):74-80. PubMed ID: 18190246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of successful implementation of population-based cancer screening programmes.
    Lynge E; Törnberg S; von Karsa L; Segnan N; van Delden JJ
    Eur J Cancer; 2012 Mar; 48(5):743-8. PubMed ID: 21788130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories.
    Wiener HG; Klinkhamer P; Schenck U; Arbyn M; Bulten J; Bergeron C; Herbert A
    Cytopathology; 2007 Apr; 18(2):67-78. PubMed ID: 17397490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Implications and details of the responsibility of radiologists in organized screening activities].
    Demuth R; Hazebroucq V; Schwebag MM
    Bull Soc Sci Med Grand Duche Luxemb; 2006; (1):37-64. PubMed ID: 16869095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening policies and coverage in Europe.
    Anttila A; von Karsa L; Aasmaa A; Fender M; Patnick J; Rebolj M; Nicula F; Vass L; Valerianova Z; Voti L; Sauvaget C; Ronco G
    Eur J Cancer; 2009 Oct; 45(15):2649-58. PubMed ID: 19699081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of timely information in national cancer screening programmes.
    Droljc A; Grbec T; Orel A
    Stud Health Technol Inform; 2009; 150():81-5. PubMed ID: 19745271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality assurance in forensic pathology.
    Ong BB; Milne N
    Malays J Pathol; 2009 Jun; 31(1):17-22. PubMed ID: 19694309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology.
    Herbert A; Bergeron C; Wiener H; Schenck U; Klinkhamer P; Bulten J; Arbyn M
    Cytopathology; 2007 Aug; 18(4):213-9. PubMed ID: 17635161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer screening: A Slovenian experience.
    Primic-Zakelj M; Repse-Fokter A
    Coll Antropol; 2007 Apr; 31 Suppl 2():23-6. PubMed ID: 17600934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality Assurance in Rehabilitation under the German Pension Insurance Scheme].
    Egner U; Gerwinn H; Buschmann-Steinhage R
    Rehabilitation (Stuttg); 2006 Aug; 45(4):221-31. PubMed ID: 16874579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
    Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
    Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving cancer control in the European Union: conclusions from the Lisbon round-table under the Portuguese EU Presidency, 2007.
    Gouveia J; Coleman MP; Haward R; Zanetti R; Hakama M; Borras JM; Primic-Zakelj M; de Koning HJ; Travado L
    Eur J Cancer; 2008 Jul; 44(10):1457-62. PubMed ID: 18325756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of effectiveness of quality-assured mammography screening in Germany: sample size considerations and design options.
    Becker N; Hakama M; Nyström L
    Eur J Cancer Prev; 2007 Jun; 16(3):225-31. PubMed ID: 17415093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assurance program for neonatal screening of glucose-6-phosphate dehydrogenase deficiency.
    Chiang SH; Wu KF; Liu TT; Wu SJ; Hsiao KJ
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():130-4. PubMed ID: 15906716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.